Bio Trunking Antimicrobial Trunking Solutions from MarshallTufflex Infection
Bio Trunking Antimicrobial Trunking Solutions from Marshall-Tufflex
Infection control – the challenges • Reduction in the transfer of microorganisms is a key objective for the NHS. Why? – There are 300, 000 hospital associated infections (HCAIs) in the UK per year. – There is a £ 270 m investment in infection control per year. – HCAIs actually cost £ 1 bn and 5, 000 deaths per year. Per person - 11 extra days in hospital and 3 times the cost!
Infection control – prevention • Where hygiene is a priority: – Providing a reduction in the transfer of bacteria via inanimate objects. – Antimicrobial PVC-U trunking supports other infection control initiatives. – It also helps to prevent discolouration and odour formation on the treated item. Prevention is better than cure!
Infection control – why silver? • Silver has been used for centuries to inhibit the growth of bacteria. + AG • Silver ions: – Provide controlled delivery – Are thermally stable – Inorganic – Non-leachable – Registration with the Environmental Protection Agency (EPA) – Compliance with the European Products Directive (BPD).
Silver – how it works • Silver ions attack bacterial cells in contact with a surface. • Solutions integral within the PVC-U provide consistent antibacterial performance. • Controlled release over product life. Bacterial Cells Ag+
Bio Trunking - testing MRSA Tests made in conjunction with material suppliers Doeflex-Ultrafresh TEST RESULTS: Marshall-Tufflex Report #2422431 LABORATORY: Thornton Research Associates Inc. , Ontario, Canada TEST ORGANISM: Methicillin Resistant Staphylococcus Aureus (MRSA) Quantitative Assessment of Activity – ISO 22196: 2007 MRSA Concentration of starting inoculum Sample Description 4. 94 x 105 CFU/m. L No. Bacteria Recovered Log Value R= [log(B/C)] % Survival 1. Flat profile – Blue Tape, White PVC – untreated control 7. 19 x 106 6. 9 ------ 2. Curved profile – Red Tape, White PVC – Treated with Ultra-Fresh CA-16 <2. 00 x 101 <1. 3 >5. 6 <0. 1% The treated curved profile (Sample 2) showed excellent control of MRSA with a greater than 99. 9% reduction in bacteria compared to the untreated flat profile (Sample 1).
Bio Trunking – testing K. pneumoniae TEST RESULTS: Marshall-Tufflex Report #2422435 LABORATORY: Thornton Research Associates Inc. , Ontario, Canada TEST ORGANISM: Klebsiella Pneumoniae Quantitative Assessment of Activity – ISO 22196: 2007 K. pneumoniae Concentration of starting inoculum Sample Description 1. 16 x 105 CFU/m. L No. Bacteria Recover ed Log Value R = [log(B/C)] % Survival 1. Flat profile – Blue Tape, White PVC – untreated control 3. 06 x 106 6. 5 ------ 2. Curved profile – Red Tape, White PVC – Treated with Ultra-Fresh CA 16 4. 01 x 102 2. 6 3. 9 <0. 1% The treated curved profile (Sample 2) showed excellent control of Klebsiella Pneumoniae with a greater than 99. 9% reduction in bacteria compared to the untreated flat profile (Sample 1). The bacteria grew on the untreated sample.
Bio Trunking Solutions Derriford Hospital, Plymouth • Odyssey Bio in 11 operating theatres. “Odyssey Bio…is a product that is likely to come to the fore in the control of infection as Trusts up and down the country tackle the continuing threat of virulent infectious diseases. ” Rob Ellis, Head of Electrical Estates, Plymouth NHS Trust.
Bio Trunking Solutions Heavitree Hospital • Odyssey Bio for the Dermatology & Lymphoedema Unit “Infection control was the over-riding factor in the specification of Odyssey Bio. It is a superb product and we are very pleased with it. ” Royal Devon & Exeter NHS Trust
Marshall-Tufflex Bio Trunking Solutions A range of trunking systems with integral antimicrobial properties. - Prevents 99. 9% of harmful bacteria growth. - No reduction in effectiveness if the trunking is damaged. - Tests to ISO 22196: 2007 Bio Trunking Solutions a caring choice for the healthcare environment
- Slides: 10